Houvenaeghel, G.; Heinemann, M.; Classe, J.-M.; Bouteille, C.; Gimbergues, P.; Azuar, A.-S.; Martino, M.; Tallet, A.; Cohen, M.; de Nonneville, A.
Omission of Completion Axillary Lymph Node Dissection for Patients with Breast Cancer Treated by Upfront Mastectomy and Sentinel Node Isolated Tumor Cells or Micrometastases. Cancers 2024, 16, 2666.
https://doi.org/10.3390/cancers16152666
AMA Style
Houvenaeghel G, Heinemann M, Classe J-M, Bouteille C, Gimbergues P, Azuar A-S, Martino M, Tallet A, Cohen M, de Nonneville A.
Omission of Completion Axillary Lymph Node Dissection for Patients with Breast Cancer Treated by Upfront Mastectomy and Sentinel Node Isolated Tumor Cells or Micrometastases. Cancers. 2024; 16(15):2666.
https://doi.org/10.3390/cancers16152666
Chicago/Turabian Style
Houvenaeghel, Gilles, Mellie Heinemann, Jean-Marc Classe, Catherine Bouteille, Pierre Gimbergues, Anne-Sophie Azuar, Marc Martino, Agnès Tallet, Monique Cohen, and Alexandre de Nonneville.
2024. "Omission of Completion Axillary Lymph Node Dissection for Patients with Breast Cancer Treated by Upfront Mastectomy and Sentinel Node Isolated Tumor Cells or Micrometastases" Cancers 16, no. 15: 2666.
https://doi.org/10.3390/cancers16152666
APA Style
Houvenaeghel, G., Heinemann, M., Classe, J. -M., Bouteille, C., Gimbergues, P., Azuar, A. -S., Martino, M., Tallet, A., Cohen, M., & de Nonneville, A.
(2024). Omission of Completion Axillary Lymph Node Dissection for Patients with Breast Cancer Treated by Upfront Mastectomy and Sentinel Node Isolated Tumor Cells or Micrometastases. Cancers, 16(15), 2666.
https://doi.org/10.3390/cancers16152666
